<?xml version="1.0" encoding="UTF-8"?>
<p>A commentary by Lamballerie and Touret summarised the studies conducted thus far on CQ and its antiviral potential in the past suggesting that it has little or no effect on many acute viral diseases such as influenza, dengue, Ebola, HIV and Nipah viruses. However, in their discussion, it was highlighted that in the case of Hepatitis C infection, HCQ used in combination with pegylated interferon and ribavirin resulted in a positive effect on reducing the viral load [
 <xref rid="B99-viruses-12-01058" ref-type="bibr">99</xref>]. 
</p>
